# IDEAYA Biosciences, Inc. Common Stock (IDYA)

IDEAYA Biosciences (IDYA) sees a surge in social media buzz, with engagements up 270% and trading volume up 95% week-over-week. Positive analyst ratings and pipeline developments are fueling investor confidence.

### About IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences, Inc. is a biotechnology company focused on developing cancer therapies.  
IDEAYA Biosciences, Inc. Common Stock uses the ticker $IDYA for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- IDEAYA Biosciences, Inc. Common Stock (IDYA) engagements hit 39.4K which is 356% higher than it's daily average.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) trading volume is up 94.96% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) social dominance is up 655.56% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) engagements is up 83.36% from the previous week.

### Price: $30.30
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$idya/time-series/close.tsv)  
The stock price has surged to a 52-week high, driven by increased social media engagement and positive analyst ratings, indicating strong investor confidence and upward momentum.  

24-Hour: -3.97%
7-Day: -5.91%
30-Day: -15.54%

1-Year High: $37.90 on 2026-01-07  
1-Year Low: $14.50 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$idya/time-series/alt_rank.tsv)  
IDEAYA Biosciences, Inc. Common Stock (IDYA) is currently AltRank #1,148 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] [---]  
[--] Month: [---] [----]  
[--] Months: [---] [---]  
[--] Year: [---] +207  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [--] on 2025-07-06  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$idya/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +26  
[--] Months: [--] +21  
[--] Year: [--] +36  
1-Year High: [--] on 2025-07-24  
1-Year Low: [--] on 2025-06-11  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$idya/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [-----]  
[--] Week: [------] +83%  
[--] Month: [-------] +19%  
[--] Months: [---------] +121%  
[--] Year: [---------] +61%  
1-Year High: [------] on 2025-10-18  
1-Year Low: [---] on 2025-05-18  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
News: [--]
X: [------]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$idya/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] -6.40%  
[--] Month: [---] +1.40%  
[--] Months: [-----] +30%  
[--] Year: [-----] +67%  
1-Year High: [---] on 2025-11-19  
1-Year Low: [--] on 2025-05-18  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
News: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$idya/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning IDEAYA Biosciences, Inc. Common Stock (IDYA) in the last [--] hours which is up 25% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -4.50%  
[--] Month: [---] +4.60%  
[--] Months: [---] -37%  
[--] Year: [-----] +93%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-06-01  

The most influential creators that mention IDEAYA Biosciences, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]     | [-----]       |
| [@TOWiU2](/creator/twitter/TOWiU2)                   | [--]    | [-----]     | [--]     | [---]         |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | [--]    | [------]    | [--]     | [---]         |
| [@Quantumup1](/creator/twitter/Quantumup1)           | [--]    | [-----]     | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [--]          |
| [@VirtualFragment](/creator/twitter/VirtualFragment) | [--]    | [---]       | [--]     | [--]          |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [--]          |
| [@Stella63592](/creator/twitter/Stella63592)         | [--]    | [--]         | [--]     | [--]          |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [--]          |
| [@linhnguyen64143](/creator/twitter/linhnguyen64143) | [--]   | [--]        | [--]     | [--]          |

[View More](/list/creators/$idya/100)
  
  
### Sentiment: 92%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$idya/time-series/sentiment.tsv)  
Current Value: 92%  
Daily Average: 75%  
[--] Week: 75% -25%  
[--] Month: 86% +24%  
[--] Months: 86% +4%  
[--] Year: 86% +18%  
1-Year High: 100% on 2025-03-17  
1-Year Low: 21% on 2025-12-16  

Most Supportive Themes:
- Pipeline Potential: (45%) The company's drug pipeline, including its Uveal Melanoma drug and DLL3 programs, is expected to have a significant market impact.
- Analyst Ratings: (25%) Positive analyst ratings from Barclays and Citizens, with price targets of $40 and $41 respectively, indicate confidence in the stock's future performance.
  
Most Critical Themes:
- Biotech Volatility: (10%) The inherent volatility of the biotech sector requires careful monitoring of overall market trends.
  
  
  
### Social Dominance: 0.0039%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$idya/time-series/social_dominance.tsv)  
Current Value: 0.0039%  
Daily Average: 0.00874%  
[--] Week: 0.014% +0.012%  
[--] Month: 0.0064% -0.0021%  
[--] Months: 0.0064% -0.0038%  
[--] Year: 0.0064% -0.0098%  
1-Year High: 0.034% on 2025-11-19  
1-Year Low: 0.0025% on 2025-08-02  
  
  
### Market Dominance: 0.00301%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$idya/time-series/market_dominance.tsv)  
Current Value: 0.00301%  
Daily Average: 0%  
1-Year High: 0.054% on 2025-03-31  
1-Year Low: 0.00207% on 2025-05-14  
  
  
### Market Cap: $2,653,662,170
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$idya/time-series/market_cap.tsv)  
Current Value: $2,653,662,170  
Daily Average: $2,246,014,172  
[--] Week: $2,653,662,170 -5.90%  
[--] Month: $2,653,662,170 -16%  
[--] Months: $2,653,662,170 +22%  
[--] Year: $2,653,662,170 +44%  
1-Year High: $3,319,050,207 on 2026-01-07  
1-Year Low: $1,269,292,170 on 2025-04-08  

### Top IDEAYA Biosciences, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@LTbioinvestor $VKTX $SRPT $CYTK $IDYA Week [--] after Poll:"  
[X Link](https://x.com/TOWiU2/status/2022432922314375625) [@TOWiU2](/creator/x/TOWiU2) 2026-02-13T22:09Z [----] followers, [---] engagements


"@chuminhua432 Hilarious slap in the face to $IDYA"  
[X Link](https://x.com/NotGenentech/status/2022361278933823830) [@NotGenentech](/creator/x/NotGenentech) 2026-02-13T17:24Z [---] followers, [---] engagements


"$CRVS Tregs are pretty integral in inducing that durative effect You can see it in the $NKTR and $CRVS data The difference is the speed of the responses: $CRVS is reaching $NKTR W16 response at W4 & [--] (don't kill me I know it's a small sample size but $CRVS is also doing this in a population that includes 40-50% dupi and JAK failures not a fully naive pt pop so gotta give credit to that) Which makes sense MOA wise #Rezpeg is only affecting the Treg side of the treg/teff equation so to get it to balance you have to dose more and for a longer period (That's why they're extending the induction"  
[X Link](https://x.com/tradingsssss/status/2022208473891844409) [@tradingsssss](/creator/x/tradingsssss) 2026-02-13T07:17Z [----] followers, [----] engagements


"$CRVS Mizuho discusses oral ITK inhibitor #soquelitinib recent AD data: 🔹 "Data were VERY excellent in terms of efficacy and also in terms of safety" 🔹 "Best-in-Class EASI-75 almost Best-in-Disease type of efficacy" 🔹 "intriguing signals that you can get durative efficacy" $NKTR $KYMR $EVMN also mentioned : Mizuho Senior Biotech Analyst @soowannaway shares his take on three key biotech trials that are scheduled to read out soon and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video: https://t.co/gnwTp8KeAW https://t.co/ktZtIrypkA : Mizuho Senior Biotech Analyst"  
[X Link](https://x.com/HOThomasWPhelps/status/2022184349622321662) [@HOThomasWPhelps](/creator/x/HOThomasWPhelps) 2026-02-13T05:41Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing